23/01/2025  13:57:44 Chg. +0.950 Volume Bid03:02:02 Ask03:02:02 Market Capitalization Dividend Y. P/E Ratio
36.780EUR +2.65% 352
Turnover: 12,909.390
-Bid Size: - -Ask Size: - 20.71 bill.EUR - -

Business description

Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care.
 

Management board & Supervisory board

CEO
Michael Sen
Management board
Sara Hennicken, Pierluigi Antonelli , Robert Möller, Michael Moser
Supervisory board
Wolfgang Kirsch, Prof. Dr. D. Michael Albrecht, Bernd Behlert , Michael Diekmann , Grit Genster , Frauke Lehmann , Prof. Dr. med. Iris Löw-Friedrich , Susanne Zeidler , Dr. Christoph Zindel , Holger Michel, Harald Steer, Oscar Romero de Paco
 

Company data

Name: Fresenius SE & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-608-0
Fax: -
E-mail: pr-fre@fresenius.com
Internet: www.fresenius.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 31/12
Free Float: 56.49%
IPO date: 18/12/1986

Investor relations

Name: Markus Georgi
IR phone: +49-6172-608-2485
IR Fax: +49-6172-608-2488
IR e-mail: ir-fre@fresenius.com

Company calendar

CW 9 | 26/02/2025 Annual Report
CW 19 | 07/05/2025 Interim Report 1st Quarter/3 Months
CW 21 | 23/05/2025 General Shareholder Meeting
CW 32 | 06/08/2025 Interim Report 2nd Quarter/6 Months
CW 45 | 05/11/2025 Interim Report 3rd Quarter/9 Months